Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy - Concepedia

Concepedia

Publication | Closed Access

Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy

31

Citations

44

References

2023

Year

Zheng Hu, Wanqiong Li, Shaomeng Chen, Danhong Chen, Ran Xu, Danlu Zheng, Xin Yang, Shuzhen Li, Xiuman Zhou, Xiaoshuang Niu,

Science China Life Sciences

Tumor ImmunologyPeptide EngineeringNovel Chimeric PeptideImmunologyTumor ImmunityPeptide TherapeuticImmune Checkpoint InhibitorPeptide SciencePeptide TherapeuticsDual BlockadeImmunotherapyMedicineRadiation Oncology

References

	Year	Citations

Page 1

Page 1